• BiomX published a shareholder letter from CEO Michael Oster outlining leadership changes and a reset of strategic priorities and financial structure.
• The letter said warrants issued in a December 2025 investment were amended from a five-year term to a one-year exercise period, with an exercise price of USD 1 per share.
• The company said it is evaluating opportunities to reposition toward sectors including defense-related applications, and is engaging with investment banks and institutional investors.
• BiomX also cited cost-reduction actions, including finalizing expenses related to closing its Maryland facility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BiomX Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-031587), on March 19, 2026, and is solely responsible for the information contained therein.